In a medical first, the children were treated with genetically engineered T-cells from another person.
A startup uses algorithms that understand the anatomy of cells to discover new uses for existing drugs.
More than half of pediatric cancer patients have genetic faults that could affect their diagnosis or be targeted by drugs.
The regulator has suggested that it treat every edit of an animal’s genome like a new drug, but some scientists think it could slow progress.
Researchers enlist smartphones and machine learning to find vocal patterns that might signal post-traumatic stress disorder or even heart disease.
Filling a gap that pharma fails to fund, a new initiative will develop vaccines to prevent outbreaks of emerging viruses.
Her death is a reminder that antibiotic-resistant bacteria are getting worse, even as they garner little attention.
A startup called Ambrosia will fill your veins with the blood of young people and empty your pockets of $8,000.
Experts warn that a potential IVF breakthrough could have unintended social consequences.
When Brian Hanley set out to test a gene therapy, he started with himself.